An Open Label, Balanced. Randomized, Two-treatment, Two-period, Two-sequence, Single Dose,Crossover, Bioequivalence Study of Primidone 50 mg Tablets of Comparing With That of Mysoline 50 mg Tablets Under Fasting Conditions.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Primidone (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
Most Recent Events
- 01 Jun 2010 New trial record
- 27 May 2010 Biomarkers information updated